Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-15

Clinical Trial Update: Efficacy and Safety of Asenapine With Placebo and Haloperidol (41023)(P05926)(COMPLETED) [Phase 3]

View source ↗

Summary

A completed Phase 3 trial evaluated the efficacy and safety of asenapine in comparison with placebo and haloperidol for schizophrenia. The study design included…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Asenapine (asenapine)
  • HALOPERIDOL (HALOPERIDOL LACTATE)

Snippet

Sponsor: Organon and Co | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED